Skip to content

Holmium Laser vs Bipolar Enucleation of a Large Volume BPH: a Randomised Controlled Study

Holmium Laser Enucleation Versus Bipolar Plasmakinetic Enucleation of a Large Volume Benign Prostatic Hyperplasia: a Randomised Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03998150
Acronym
BPH
Enrollment
64
Registered
2019-06-26
Start date
2016-11-01
Completion date
2019-03-08
Last updated
2019-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BPH With Urinary Obstruction, Male

Keywords

BPH, enucleation, Prostate, LUTS, IPSS, quality of life, Large prostate

Brief summary

To compare bipolar plasmakinetic enucleation versus holmium laser enucleation for management of large BPH.

Detailed description

To compare safety and efficacy of bipolar plasmakinetic enucleation (BPEP) versus holmium laser enucleation (HoLEP) for management of large BPH (\>80gm).

Interventions

cystoscopic transurethral enucleation of the prostate using Holmium laser (Asclepion MultiPulse HoPlus 110W and Lumenis pulse 100W and 120W)

PROCEDUREBipolar plasma kinetic enucleation of the prostate

cystoscopic transurethral enucleation of the prostate using bipolar plasma kinetic energy (KLS Martin Maxium or Covidien Force Triad)

Sponsors

Theodor Bilharz Research Institute
CollaboratorOTHER
Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients suffering from LUTS secondary to infravesical obstruction from BPH * failed medical treatment * International Prostate Symptom Score (IPSS) \> 13 * a peak urinary flow rate (Qmax) \< 15 ml/sec * a prostate size ≥ 80 gm

Exclusion criteria

* presence of a urethral stricture * neurological disorder * bladder cancer * prostate cancer * previous history of bladder neck surgery or TURP

Design outcomes

Primary

MeasureTime frameDescription
hemoglobin drop postoperatively (gm/dL)Immediate postoperativelydifference in hemoglobin concentration postoperatively vs preoperatively
operative timeduring surgeryoperative time in minutes

Secondary

MeasureTime frameDescription
post-voiding residual urineone yearpostvoiding residual urine (ml)
complications (%)one yearintraoperative and postoperative complications including blood transfusion, capsular perforation, irritative symptoms, SUI, urethral stricture, bladder neck contracture, urinary retention.
Quality of life (QoL) section of International prostate symptom score (IPSS)one yearone question scored from 0 up to 6 (6 is worst)
International prostate symptom score (IPSS)one yearan international commonly used score ranging from 0 - 35 (the worst is 35) evaluating voiding and storage urinary symptoms using 7 questions each one is scored from 0 to 5 according to severity of symptom
urine flowone yearQmax (ml/s),

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026